KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,139 | -24.6% | 84,432 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $150,007 | -89.0% | 83,803 | -10.6% | 0.00% | -95.0% |
| Q3 2020 | $1,368,000 | -27.6% | 93,706 | -6.1% | 0.02% | -20.0% |
| Q2 2020 | $1,889,000 | +427.7% | 99,749 | +148.2% | 0.02% | +525.0% |
| Q1 2016 | $358,000 | -42.6% | 40,184 | -14.6% | 0.00% | -33.3% |
| Q4 2015 | $624,000 | -89.4% | 47,071 | -15.7% | 0.01% | 0.0% |
| Q3 2015 | $5,883,000 | +510.3% | 55,870 | +57.7% | 0.01% | -25.0% |
| Q2 2015 | $964,000 | +77.9% | 35,431 | +100.1% | 0.01% | +100.0% |
| Q1 2015 | $542,000 | – | 17,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |